☆ 4.5 Letter

Sarcoidosis During Anti-Tumor Necrosis Factor-alpha Therapy: No Relapse After Rechallenge

JOURNAL OF RHEUMATOLOGY (2009)

Journal

JOURNAL OF RHEUMATOLOGY

Volume 36, Issue 12, Pages 2847-2848

Publisher

J RHEUMATOL PUBL CO

DOI: 10.3899/jrheum.090307

Keywords

-

Categories

Rheumatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Gastroenterology & Hepatology

Immunomodulators after the discontinuation of anti-tumor necrosis factor-alpha antibody treatment and relapse in ulcerative colitis: A multicenter cohort study

Kunio Asonuma, Keiji Ozeki, Hajime Yamazaki, Shinji Okabayashi, Soh Okano, Ryo Ozaki, Nobuaki Nishimata, Hiroki Kiyohara, Naoki Ichinari, Taku Kobayashi, Masahiro Yamada, Mao Matsubayashi, Yoko Yokoyama, Shoko Arimitsu, Junji Umeno, Yoshinori Munetomo, Akira Andoh, Shinichiro Shinzaki, IBD Terakoya Grp

Summary: The use of immunomodulators after discontinuing anti-TNF-alpha antibody treatment was not significantly associated with relapse in patients with UC. Careful patient follow-up is necessary when discontinuing due to side effects or in younger patients at the time of discontinuation.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023)

Add to Collection

Article Cell Biology

Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy

Dagmar Schierova, Radka Roubalova, Martin Kolar, Zuzana Stehlikova, Filip Rob, Zuzana Jackova, Stepan Coufal, Tomas Thon, Martin Mihula, Martin Modrak, Miloslav Kverka, Lukas Bajer, Klara Kostovcikova, Pavel Drastich, Jana Hercogova, Michaela Novakova, Martin Vasatko, Milan Lukas, Helena Tlaskalova-Hogenova, Zuzana Jiraskova Zakostelska

Summary: This study investigated the longitudinal effect of anti-TNF therapy on gut microbiota composition and immune response in IBD patients. The results showed differences in microbiota diversity between healthy controls, Crohn's disease, and ulcerative colitis patients, with patients' microbiota becoming more similar to healthy controls after treatment. Additionally, increased IgM levels against specific gut commensals were observed after anti-TNF therapy.

CELLS (2021)

Add to Collection

Article Medicine, General & Internal

Association of Anti-Tumor Necrosis Factor Therapy With Mortality Among Veterans With Inflammatory Bowel Disease

Shirley Cohen-Mekelburg, Beth I. Wallace, Tony Van, Wyndy L. Wiitala, Shail M. Govani, Jennifer Burns, Rachel Lipson, Huifeng Yun, Jason Hou, James D. Lewis, Jason A. Dominitz, Akbar K. Waljee

Summary: This study in a national cohort of veterans examined the association between the use of anti-TNF or corticosteroids and all-cause mortality in patients with IBD. Results suggest that anti-TNF therapy may be linked to reduced mortality compared with prolonged corticosteroid use, particularly among patients with Crohn disease.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Anti-Inflammatory Characteristics of Local Anesthetics: Inhibition of TNF-α Secretion of Lipopolysaccharide-Stimulated Leucocytes in Human Blood Samples

Stefan Weinschenk, Carsten Weiss, Justus Benrath, Volker von Baehr, Thomas Strowitzki, Manuel Feisst

Summary: This study investigated the effects of four local anesthetics on TNF-alpha secretion in human leucocytes. The results showed that all four local anesthetics reduced TNF-alpha secretion and can be potential candidates for treating overactive immune reactions and chronic inflammation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Anti-Inflammatory Effect and Cellular Uptake Mechanism of Carbon Nanodots in in Human Microvascular Endothelial Cells

Sarah Belperain, Zi Yae Kang, Andrew Dunphy, Brandon Priebe, Norman H. L. Chiu, Zhenquan Jia

Summary: CNDs, as a novel form of nanoparticles, have shown potential anti-inflammatory properties in reducing TNF-alpha induced endothelial cell inflammation. This finding may open up a new direction for the treatment of cardiovascular diseases.

NANOMATERIALS (2021)

Add to Collection

Article Food Science & Technology

Antinociceptive and Anti-Inflammatory Effects of Recombinant Crotamine in Mouse Models of Pain

Jong Yeon Park, Bich Hang Do, Ju-Seung Lee, Hyun Cheol Yang, Anh Ngoc Nguyen, Martin Krupa, Chong Jai Kim, Yeon Jin Jang, Han Choe

Summary: The study found that recombinant crotamine has significant antinociceptive and anti-inflammatory effects, which are not related to the opioid receptor. Additionally, the effects of intraperitoneal or intraplantar recombinant crotamine are related to TNF-alpha.

TOXINS (2021)

Add to Collection

Review Endocrinology & Metabolism

Anti- and non-tumor necrosis factor-α-targeted therapies effects on insulin resistance in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis

Chrong-Reen Wang, Hung-Wen Tsai

Summary: Insulin resistance (IR) is a crucial mechanism leading to the development of diabetes mellitus (DM), requiring higher than normal insulin concentrations to maintain euglycemic status. Many human inflammatory disorders, particularly autoimmune-mediated arthritis conditions, have been associated with an increased risk of IR, especially during active disease states. Using biologic agents and small molecule-targeted drugs can reduce IR and improve diabetic hyperglycemia in autoimmune-mediated arthritis.

WORLD JOURNAL OF DIABETES (2021)

Add to Collection

Article Clinical Neurology

Clinical course of central nervous system demyelinating neurological adverse events associated with anti-TNF therapy

Rosa Cortese, Luca Prosperini, Alessandro Stasolla, Shalom Haggiag, Veronica Villani, Isabella Laura Simone, Claudio Gasperini, Carla Tortorella

Summary: This study described 8 patients who experienced demyelinating CNS events while on anti-TNF alpha treatment, with most patients showing a good medium-term prognosis. The results support an association between anti-TNF alpha treatment and demyelinating events, and suggest that prompt discontinuation of the drug may lead to a favorable demyelinating disease outcome.

JOURNAL OF NEUROLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Levels of TNF-α and Soluble TNF Receptors in Normal-Weight, Overweight and Obese Patients with Dilated Non-Ischemic Cardiomyopathy: Does Anti-TNF Therapy Still Have Potential to Be Used in Heart Failure Depending on BMI?

Elzbieta Lazar-Poloczek, Ewa Romuk, Wojciech Jachec, Wiktoria Stanek, Bartosz Stanek, Monika Szoltysik, Tomasz Techmanski, Maja Hasterok, Celina Wojciechowska

Summary: This study aimed to compare the levels of adipokines, TNF-alpha, and soluble receptors in heart failure patients with different BMI. The study found that obese patients had the lowest NT-proBNP concentrations and higher leptin levels. TNF-alpha concentrations were positively correlated with sTNFr1 in all groups. Higher levels of sTNFr1 were associated with higher sTNFr2 and CRP levels. Obese patients may respond better to anti-TNF therapy.

BIOMEDICINES (2022)

Add to Collection

Article Pharmacology & Pharmacy

Permeability, anti-inflammatory and anti-VEGF profiles of steroidal-loaded cationic nanoemulsions in retinal pigment epithelial cells under oxidative stress

Ana R. Fernandes, Tiago dos Santos, Pedro L. Granja, Elena Sanchez-Lopez, Maria L. Garcia, Amelia M. Silva, Eliana B. Souto

Summary: This study found that using cationic nanoemulsions to deliver triamcinolone acetonide (TA) can reduce the production of tumor necrosis factor alpha (TNF-alpha), which in turn decreases VEGF levels, indicating the potential use of these nanoemulsions for the treatment of age-related macular degeneration (AMD).

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)

Add to Collection

Article Oncology

IL-6, TNF-α and IL-12p70 levels in patients with colorectal cancer and their predictive value in anti-vascular therapy

Jingxian Zheng, Xiaojie Wang, Jiami Yu, Zhouwei Zhan, Zengqing Guo

Summary: This study aimed to analyze the levels of IL-6, TNF-alpha, and IL-12p70 in colorectal cancer patients and evaluate their predictive significance for the clinical efficacy of anti-vascular therapy combined with chemotherapy. The results showed that IL-6 and IL-12p70 levels were related to lymph node metastasis and TNM staging, while TNF-alpha levels were associated with the degree of differentiation. IL-12p70 level could be used as a predictor of the efficacy of anti-vascular treatment for advanced colorectal cancer.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Chemistry, Physical

Tannic acid assisted anti-TNF-α nanobody assembly modulating the epithelial barrier dysregulation of allergic rhinitis

Shuilian Fu, Zhiting Cao, Baolian Huang, Te Yin, Chujun Huang, Zhiqian Bi, Yingying Yao, Xiaoyao Chang, Hongqin Zhuang, Zi-Chun Hua

Summary: The dysfunction of tight junctions in the nasal epithelial barrier leads to increased allergen penetration and cytokine release, causing allergic rhinitis. TNF-a inhibitors have been used for treating autoimmune diseases, but their role in AR is unclear. In this study, an anti-TNF-a nanobody (V) assembled with tannic acid (V/TA) effectively inhibited cytokine release in an AR murine model. V/TA treatment restored infiltration of inflammatory cells, mucus-secreting cells, and mast cells to normal levels. The therapeutic effect was associated with reduced levels of TJ molecules and enhanced by tannic acid, without observed toxicity. This study offers a promising delivery strategy for treating complicated allergic rhinitis with superior epithelial barrier restoration compared to the commercial drug Infliximab.

NANO RESEARCH (2023)

Add to Collection

Article Nutrition & Dietetics

Anti-Inflammatory and Gut Microbiota Modulating Effects of Probiotic Lactobacillus paracasei MSMC39-1 on Dextran Sulfate Sodium-Induced Colitis in Rats

Boonyarut Ladda, Chittapon Jantararussamee, Wisuit Pradidarcheep, Anongnard Kasorn, Udomlak Matsathit, Malai Taweechotipatr

Summary: This study examined the properties of three probiotic strains in colorectal adenocarcinoma cells. It was found that the probiotic L. paracasei strain MSMC39-1 significantly suppressed TNF-a secretion in the cells. Further experiments showed that this strain reduced liver enzyme levels, inhibited TNF-a secretion in colon and liver tissues, alleviated colon and liver histopathology, and increased beneficial bacteria in the gut.

NUTRIENTS (2023)

Add to Collection

Article Rheumatology

Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post hoc analysis

Samantha Louise Smith, Sheree Alexander, Nisha Nair, Sebastien Viatte, Stephen Eyre, Kimme L. Hyrich, Ann W. Morgan, Anthony G. Wilson, John D. Isaacs, Darren Plant, Anne Barton

Summary: The study aimed to explore whether the inflammatory protein MRP8/14 can serve as a biomarker for treatment response in rheumatoid arthritis (RA) patients receiving tumor necrosis factor (TNF) inhibitors. The results showed that in the 3-component and 2-component models, patients with high pre-treatment levels of MRP8/14 were 1.92 and 2.03 times more likely to be classified as EULAR responders compared to those with low levels. However, no significant associations were observed in the 4-component model. Conclusion: Apart from its correlation with CRP, there is no evidence to suggest that MRP8/14 explains additional variability in response to TNFi in RA patients beyond CRP alone.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Add to Collection

Article Infectious Diseases

Anti-Biofilm and Antibacterial Activities of Cycas media R. Br Secondary Metabolites: In Silico, In Vitro, and In Vivo Approaches

Nashwah G. M. Attallah, Omnia Momtaz Al-Fakhrany, Engy Elekhnawy, Ismail A. Hussein, Moataz A. Shaldam, Najla Altwaijry, Moneerah J. Alqahtani, Walaa A. Negm

Summary: This study evaluated the effects of secondary metabolites from Cycas media R. Br on Enterococcus faecalis isolates. The results showed that SOTE exhibited higher antibacterial and antivirulence activities compared to GINK. SOTE inhibited biofilm formation and reduced inflammation in the liver and spleen, suggesting its potential as a promising compound for further research.

ANTIBIOTICS-BASEL (2022)

Add to Collection

Article Allergy

Association between elevated serum triglycerides and asthma in patients with obesity: An explorative study

Cathelijne M. van Zelst, Geertje M. de Boer, Yasemin Turk, Astrid van Huisstede, Johannes C. C. M. In't Veen, Erwin Birnie, Bianca M. Boxma-de Klerk, Gerdien A. Tramper-Stranders, Gert-Jan Braunstahl

Summary: The study found that elevated serum triglycerides were significantly associated with the presence of asthma in patients with obesity, suggesting that higher lipid levels could be a potential factor contributing to the development of asthma.

ALLERGY AND ASTHMA PROCEEDINGS (2021)

Add to Collection

Article Allergy

Alpine altitude climate treatment for severe and uncontrolled asthma: An EAACI position paper

Karin B. Fieten, Marieke T. Drijver-Messelink, Annalisa Cogo, Denis Charpin, Milena Sokolowska, Ioana Agache, Luis Manuel Taborda-Barata, Ibon Eguiluz-Gracia, Gerrit J. Braunstahl, Sven F. Seys, Maarten van den Berge, Konrad E. Bloch, Silvia Ulrich, Carlos Cardoso-Vigueros, Jasper H. Kappen, Anneke Ten Brinke, Markus Koch, Claudia Traidl-Hoffmann, Pedro da Mata, David J. Prins, Suzanne G. M. A. Pasmans, Sarah Bendien, Maia Rukhadze, Mohamed H. Shamji, Mariana Couto, Hanneke Oude Elberink, Diego G. Peroni, Giorgio Piacentini, Els J. M. Weersink, Matteo Bonini, Lucia H. M. Rijssenbeek-Nouwens, Cezmi A. Akdis

Summary: The European Alpine Altitude Climate Treatment (AACT) programs combine the physical characteristics of altitude with avoidance of environmental triggers in alpine climate and a personalized multidisciplinary pulmonary rehabilitation approach, showing beneficial effects on immunomodulation, quality of life improvement, and prevention of asthma exacerbations.

ALLERGY (2022)

Add to Collection

Article Respiratory System

Mepolizumab improves work productivity, activity limitation, symptoms, and rescue medication use in severe eosinophilic asthma

Frank C. Albers, Daniel J. Bratton, Necdet B. Gunsoy, Sarah M. Cockle, Rafael Alfonso-Cristancho, Gert-Jan Braunstahl

Summary: This study investigated the effects of mepolizumab on patients with severe eosinophilic asthma using data from previous randomized controlled trials. The results showed that mepolizumab improved activity limitation, work productivity, symptoms, and rescue medication use in these patients.

CLINICAL RESPIRATORY JOURNAL (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Home-based intravenous treatment with reslizumab for severe asthma in the Netherlands-An evaluation

S. A. Bendien, M. M. van Leeuwen, H. S. Lau, A. Ten Brinke, L. E. Visser, E. M. de Koning, G. J. Braunstahl

Summary: This study demonstrates that intravenous reslizumab can be safely and successfully delivered in an outpatient setting, though not all patients prefer home administration and individual needs should be considered.

RESPIRATORY MEDICINE (2022)

Add to Collection

Article Respiratory System

STOP: an open label crossover trial to study ICS withdrawal in patients with a combination of obesity and low-inflammatory asthma and evaluate its effect on asthma control and quality of life

Jan A. Witte, Gert-Jan Braunstahl, Wouter J. B. Blox, Susan C. van t Westeinde, Johannes C. C. M. In t Veen, Jasper H. Kappen, Elisabeth F. C. van Rossum

Summary: This study aims to assess the safety of withdrawing inhaled corticosteroids (ICS) in patients with T2-low asthma and obesity, while maintaining asthma control. It provides valuable insights into the characteristics of T2-low asthma in obese patients and may discover new treatable traits.

BMC PULMONARY MEDICINE (2022)

Add to Collection

Article Respiratory System

Antibiotic Prescriptions in Hospitalized Patients with an Exacerbation COPD and a Proven Influenza or RS Virus Infection

Sigrid van Brummelen, Gerdien Tramper-Stranders, Kelly Jonkman, Geertje de Boer, Johannes In 't Veen, Gert-Jan Braunstahl

Summary: The prescription of antibiotics in hospitalized COPD patients with a proven viral infection is common practice, despite guidelines providing limited guidance. This retrospective cohort study found that antibiotic treatment was correlated with X-ray infiltrates and plasma CRP levels, but did not significantly impact outcomes such as hospitalization days and mortality. The study suggests that a significant reduction in antibiotic use is feasible and future guidelines should include recommendations for antibiotic stewardship.

INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Efficacy and safety of dupilumab as add-on therapy for patients with severe asthma: A real-world Dutch cohort study

John C. Thelen, Cathelijne M. van Zelst, Sigrid E. van Brummelen, Simone Rauh, Jasper H. Kappen, Johannes C. C. M. in't Veen, Jasper H. Kappen, Gert-Jan Braunstahl

Summary: The study demonstrates that adding dupilumab as a treatment for severe uncontrolled asthma leads to significant improvements in asthma control, quality of life, and reduction in exacerbation rate and dependency on oral corticosteroids.

RESPIRATORY MEDICINE (2023)

Add to Collection

Letter Respiratory System

The effect of beclomethasone-formoterol versus placebo on chronic cough in patients with non-CF bronchiectasis: the FORZA randomised controlled trial

Tjeerd van der Veer, Johanna Margaretha de Koning Gans, Gerrit J. Braunstahl, Angelina L. P. Pieters, Johanna M. W. van den Berg, Rogier A. S. Hoek, Lieke S. J. Kamphuis, Marleen Bakker, Alain V. F. Dubois, Joachim G. J. V. Aerts, Menno M. van der Eerden

EUROPEAN RESPIRATORY JOURNAL (2023)

Add to Collection

Article Respiratory System

ERS International Congress 2022: highlights from the Airway Diseases Assembly

Augusta Beech, Andrea Portacci, Beatrice Herrero-Cortina, Alexander G. Mathioudakis, Carolina Gotera, Lena Uller, Fabio Luigi Massimo Ricciardolo, Pavol Pobeha, Robert J. Snelgrove, Gert-Jan Braunstahl, Apostolos Bossios, Omar Usmani, Sachin Ananth

Summary: The European Respiratory Society (ERS) held an in-person meeting in Barcelona, Spain, marking the return of face-to-face congresses after two years of virtual events. The ERS Congress 2022 showcased a wide range of sessions and presentations, including thematic poster discussions, oral presentations, and symposia. Assembly 5, focused on airway diseases, asthma, COPD, and chronic cough, presented key recent findings in the field.

ERJ OPEN RESEARCH (2023)

Add to Collection

Article Multidisciplinary Sciences

Type-2 CD8+ T-cell formation relies on interleukin-33 and is linked to asthma exacerbations

Esmee K. van der Ploeg, Lisette Krabbendam, Heleen Vroman, Menno van Nimwegen, Marjolein J. W. de Bruijn, Geertje M. de Boer, Ingrid M. Bergen, Mirjam Kool, Gerdien A. Tramper-Standers, Gert-Jan Braunstahl, Danny Huylebroeck, Rudi W. Hendriks, Ralph Stadhouders

Summary: CD8+ cytotoxic T cells can also produce type-2 cytokines in severe asthma patients, and their abundance is associated with increased disease burden, higher exacerbation rates, and steroid insensitivity. The type-2 skewing of lung Tc cells in asthma is controlled by conventional type-1 dendritic cells and IFN gamma. Interleukin-33 (IL-33) critically promotes type-2 cytokine production by lung Tc cells in experimental allergic airway inflammation.

NATURE COMMUNICATIONS (2023)

Add to Collection

Article Immunology

3D chromatin reprogramming primes human memory T(H)2 cells for rapid recall and pathogenic dysfunction

Anne Onrust-van Schoonhoven, Marjolein J. W. de Bruijn, Bernard Stikker, Rutger W. W. Brouwer, Gert-Jan Braunstahl, Wilfred F. J. van IJcken, Thomas Graf, Danny Huylebroeck, Rudi W. Hendriks, Gregoire Stik, Ralph Stadhouders

Summary: This study reveals that human CD4(+) memory T helper 2 (T(H)2) cells undergo chromatin reprogramming at both one-dimensional and three-dimensional levels to efficiently recall an inflammatory transcriptional program. Distal enhancers organized in long-range three-dimensional chromatin hubs are responsible for epigenetically priming recall genes in memory T(H)2 cells. Key recall genes are precisely controlled within dedicated topologically associating domains through activation-associated promoter-enhancer interactions mediated by AP-1 transcription factors. Aberrant transcriptional control of recall responses is linked to chronic inflammation in resting memory T(H)2 cells from asthma patients. These findings highlight the importance of stable multiscale reprogramming of chromatin organization in T cell immunological memory and dysfunction.

SCIENCE IMMUNOLOGY (2023)

Add to Collection

Article Respiratory System

The effect of the COVID-19 pandemic on severe asthma care in Europe: will care change for good?

Katrien Eger, Dora Paroczai, Alison Bacon, Florence Schleich, Svetlana Sergejeva, Arnaud Bourdin, Isabelle Vachier, Eleftherios Zervas, Konstantinos Katsoulis, Dimosthenis Papapetrou, Konstantinos Kostikas, Zsuzsanna Csoma, Enrico Heffler, Giorgio Walter Canonica, Ineta Grisle, Kristina Bieksiene, Jolita Palacionyte, Anneke Ten Brinke, Simone Hashimoto, Frank W. J. M. Smeenk, Gert-Jan Braunstahl, Simone van der Sar, Florin Mihaltan, Natalia Nenasheva, Marina Peredelskaya, Biljana Zvezdin, Ivan Cekerevac, Sanja Hromis, Vojislav Cupurdija, Zorica Lazic, Branislava Milenkovic, Sanja Dimic-Janjic, Valentyna Yasinska, Barbro Dahlen, Apostolos Bossios, Nikolaos Lazarinis, David Aronsson, Arne Egesten, Abul Kashem Mohammad Munir, Lars Ahlbeck, Christer Janson, Sabina Skrgat, Natalija Edelbaher, Joerg Leuppi, Fabienne Jaun, Jochen Rudiger, Nikolay Pavlov, Pietro Gianella, Reta Fischer, Florian Charbonnier, Rekha Chaudhuri, Steven James Smith, Simon Doe, Michelle Fawdon, Matthew Masoli, Liam Heaney, Hans Michael Haitchi, Ramesh Kurukulaaratchy, Olivia Fulton, Betty Frankemolle, Toni Gibson, Karen Needham, Peter Howarth, Ratko Djukanovic, Elisabeth Bel, Michael Hyland

Summary: During the COVID-19 pandemic, video/phone consultations and home administration of biologics were common in the care of severe asthma. Most patients were satisfied with these changes, and many doctors expect them to continue in the future care of severe asthma.

ERJ OPEN RESEARCH (2022)

Add to Collection

Article Allergy

Voice bubbling therapy for vocal cord dysfunction in difficult-to-treat asthma - a pilot study

S. C. Eindhoven, Y. Turk, T. van der Veer, M. Oosterbaan-Beks, B. Goes-de Graaff, S. A. Bendien, J. de Kluijver, J. W. Arendse, T. Hooft van Huysduynen, J. C. C. M. In 't Veen, G. J. Braunstahl

Summary: Voice bubbling therapy may increase pCO2 levels in patients with difficult-to-treat asthma, but does not improve asthma control or quality of life.

JOURNAL OF ASTHMA (2022)

Add to Collection

Meeting Abstract Respiratory System

Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19

Jurjan Aman, Erik Duijvelaar, Liza Botros, Azar Kianzad, Job Schippers, Patrick Smeele, Sara Azhang, Imke Bartelink, Pierre Bet, Wim Boersma, Karin Boomars, Peter Bonta, Lieuwe Bos, Job Van Bragt, Gert-Jan Braunstahl, Lucas Celant, Katrien Eger, Miranda Geelhoed, Yurika Van Glabbeek, Hans Grotjohan, Laura Hagens, Chris Happe, Leo Heunks, Michel Van Den Heuvel, Wouter Hoefsloot, Rianne Hoek, Romke Hoekstra, Herman Hofstee, Arthur Vanhove, Nicole Juffermans, Marije Lammers, Renate Kos, Marleen Kemper, Peter Kunst, Ivo Van Der Lee, Laurien Van Der Lee, Pearl Mau-Asam, Anke-Hilse Maitland-Van Der Zee, Adinda Mieras, Esther Nossent, Marieke Overbeek, Laurien Oswald, Nienke Paternotte, Carol Pamplona, Niels Pronk, Michiel De Raaf, Elise Slob, Ary Serpa Neto, Marcus Schultz, Marry Smit, Frank Smeenk, Josien Smits, Janneke Stalenhoef, Pieter Roel Tuinman, Jeroen Wessels, Jessy Van Wezenbeek, Anton Vonk Noordegraaf, Frances Handoko-De Man, Harm Jan Bogaard

EUROPEAN RESPIRATORY JOURNAL (2021)

Add to Collection

Article Medicine, General & Internal

Pneumomediastinum in a patient with COVID-19 due to diffuse alveolar damage

Frank Heijboer, Laurien Oswald, Sander Cretier, Gert-Jan Braunstahl

Summary: This study reported a case of pneumomediastinum in a COVID-19 patient, suggesting that the pneumomediastinum was caused by COVID-19-related alveolar damage rather than the use of HFNC. After restarting HFNC, symptoms did not worsen, indicating that HFNC may not be the cause of pneumomediastinum.

BMJ CASE REPORTS (2021)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.